CYP4A22 and cancer: Interestingly, 5 HARM lncRNAs (CYP4A22-AS1, AC019080.5, AP000695.2, AP000695.1, and LINC01094) presented associations with immune in recently published studies [42, 43, 51, 52, 53], suggesting the roles of HARM in cancer immunity modulation.